APP and Alzheimer disease: Their ability to inhibit long-term potentiation (LTP) and many other critical neuronal activities is responsible for the classic model of synaptic plasticity and memory loss in vivo, for example, in middle-aged Tg2576 mice, which are equipped with a variant of human amyloid-β precursor protein (APP) associated with AD and in culture cells [9,10,11,12].